KR101679671B1 - System for extracting regenerative cells - Google Patents
System for extracting regenerative cells Download PDFInfo
- Publication number
- KR101679671B1 KR101679671B1 KR1020090102082A KR20090102082A KR101679671B1 KR 101679671 B1 KR101679671 B1 KR 101679671B1 KR 1020090102082 A KR1020090102082 A KR 1020090102082A KR 20090102082 A KR20090102082 A KR 20090102082A KR 101679671 B1 KR101679671 B1 KR 101679671B1
- Authority
- KR
- South Korea
- Prior art keywords
- unit
- chamber
- inlet portion
- cells
- passage
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/04—Cell isolation or sorting
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M45/00—Means for pre-treatment of biological substances
- C12M45/05—Means for pre-treatment of biological substances by centrifugation
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Sustainable Development (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- External Artificial Organs (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
A regenerative cell extraction system is disclosed. A regenerative cell extraction system according to an embodiment of the present invention includes a first unit, a second unit, and a transfer unit. The first unit collects tissue by vacuum inhalation, separates blood contaminants from the tissue harvested by stirring and centrifuging, and separates the cells from the separated tissue of the blood contaminant to suspend cells suspended in the liquid . The second unit is charged with cells suspended in the liquid from the first unit, separates the regenerative cells by centrifugation, and is smaller in capacity than the first unit. The transfer unit is connected between the first unit and the second unit and injects wash water into the first unit and the second unit and transfers the extract from the first unit and the second unit to the corresponding bags And the cells suspended in the liquid extracted from the first unit are injected into the second unit or the tissue and cell contaminants are transferred. The tissue is an adipose tissue, and the regenerating cell is an adipose-derived stem cell.
Description
More particularly, the present invention relates to a regenerative cell extracting system, and more particularly, to a method and apparatus for extracting adipose tissue and separating regenerated cells from adipose tissue by an automated program in a closed state. In each step, pure adipose tissue, The present invention relates to a regenerative cell extracting system capable of selectively obtaining oil and fat-derived stem cells and easily regulating the amount of regenerated cells to be harvested.
Stem cells are defined as cells that have clonogenic and self-renewal capabilities that can differentiate into multiple cell lines under specific conditions. Embryonic stem cells are derived from mammalian embryos at the stage of blastocyst and have the ability to differentiate into almost all cells present in the body whereas adult stem cells are cells that are present in very small amounts in postnatal differentiated tissues, It is the cell that holds the ability of the cell. Adult stem cells offer real advantages over embryonic stem cells. Unlike embryonic stem cells, adult stem cells can be extracted from patients themselves without causing ethical problems. They are abundant in supply and are inherent in various tissues of the human body. The most available sources of adult stem cells are bone marrow, peripheral blood, cord / umbilical cord blood, and adipose tissue, as confirmed in recent studies. These cells can maintain, produce, and replace final differentiated cells in their own specific tissues as a result of physiological cell turnover or wound damage.
This ability, called cell plasticity, has led to the development of therapeutic applications aimed at the regeneration of defective tissues, with the aim of restoring the physiology and function of diseased organs. Adult stem cells can not only produce hematopoietic cells as known decades ago, but also can produce blood vessels, muscles, bones, cartilage, skin, nerves and the like, as recently discovered. These cells are known as mesenchymal stem cells. In addition, platelets made from platelet concentrates can be used to accelerate wound healing and, as a result, can play a role in regenerative medicine that helps in the reconstitution of tissues such as bones, skin or other tissues.
Recently, adipose tissue has been found to be a source of stem cells, progenitor cells and substrate materials suitable for therapeutic applications. Adipose tissue is also a rich source of vascular endothelial cells, which can play a role in tissue regeneration and tissue engineering by stimulating growth of new blood vessels and stimulating stem and progenitor cell growth.
However, although many devices have been developed for the collection of cells from adipose tissue, these devices do not adequately accommodate a suction device for collection of adipose tissue, or partial or complete automation from collection of adipose tissue to treatment of tissue . There is also the problem of the lack of a partial or complete sealing system from the collection of adipose tissue to the treatment of tissue and the resulting contamination problems.
Thus, the process from the collection of adipose tissue to the treatment of tissue is completely automated by the program in a closed state, and the purity of regenerating cells, that is, stem cells, taken from adipose tissue is improved, It is necessary to develop a method and apparatus for reducing the need for manipulation after extraction of cells.
SUMMARY OF THE INVENTION The present invention has been made in view of the above problems, and it is an object of the present invention to provide a method and a device for producing a tissue- The present invention provides a regenerative cell extracting system that can be reduced to an amount that can be used immediately and reduces the necessity of separate operation after extraction of cells.
According to an aspect of the present invention, there is provided a regeneration cell extracting system including a first unit, a second unit, and a transfer unit.
The first unit collects tissue by vacuum inhalation, separates blood contaminants from the tissue collected by stirring and centrifuging, separates the cells from the separated tissue of blood contaminants, .
The second unit is charged with cells suspended in the liquid from the first unit, separates the regenerative cells by centrifugation, and is smaller in capacity than the first unit.
The transfer unit is connected between the first unit and the second unit and injects wash water into the first unit and the second unit and transfers the extract from the first unit and the second unit to the corresponding bags And the cells in a state suspended in the liquid extracted from the first unit are introduced into the second unit or the tissue and cell contaminants are transferred.
The tissue is an adipose tissue, and the regenerating cell is an adipose-derived stem cell.
The first unit includes a cylindrical upper body portion, a middle body portion integrally formed at a lower portion of the upper body portion and inclined toward the center toward the lower side, and a middle body portion integrally formed with the middle body portion, A first chamber having a lower body portion which is smaller than the inner diameter of the portion and extends with the same inner diameter and a lid portion which is integrally formed on the upper surface of the upper body portion and covers the upper surface, Wherein the first chamber and the second chamber are separated from each other by a predetermined distance from the bottom surface of the lower body part, the tissue being introduced into the first chamber through the upper part of the center tube, A central tube,
At least one first wing portion is formed in the direction of the center pipe to smooth agitation of the tissue collected on the inner wall surface of the middle body portion of the first chamber.
Wherein the first chamber surrounds the center pipe and is inserted into the guide hole and is formed integrally with the center pipe and has a negative pressure pipe for making the first chamber at a negative pressure state, A retainer is mounted between the sound pressure pipes so that the first chamber rotates independently of the center pipe and the sound pressure pipe while maintaining the hermeticity.
The lower end of the center pipe is spaced apart from the bottom of the lower body part by 0.1 mm to 3 mm on the bottom face. At least one auxiliary vane protruding outward is formed in a portion of the center tube inserted into the first chamber.
A bearing for smoothly rotating the first chamber may be further installed between the wall surface defining the guide hole and the sound pressure pipe together with the retainer, A filter capable of holding a foreign matter can be mounted inside the lower body portion of the lower portion of the main pipe.
Wherein the second unit comprises: an inlet portion having a predetermined diameter and extending vertically downward; and a cylindrical upper portion having an inner diameter increasing from the lower end toward the lower portion of the cell separating portion, A second chamber formed integrally with the lower portion of the upper body portion and extending downwardly and having a predetermined inner diameter, and a second chamber extending from the lower end of the inlet portion to the cell separating portion, A passage for discharging a physiological buffer solution other than the regenerating cells existing in the second chamber is formed between the upper plate and the upper plate, and the passage formed inside the inlet is formed to correspond to the inner surface of the upper plate, A first inner inlet portion having a first inner diameter and a second inner diameter larger than the first inner diameter, The second chamber having a first inner inlet portion and a second inner inlet portion having a first inner diameter and a second inner diameter; And a passage for discharging the regenerative cells formed on the bottom surface of the lower body portion of the second chamber, the passage being inserted into the second chamber through the inner side of the inlet tube and longer than the inlet tube Which is inserted between an outer wall surface of the second inner inlet portion and an inner wall surface of the inlet portion and discharged through a path between the upper plate portion and the lower plate portion, And a discharge pipe.
The second chamber is independently rotated by the retainer to maintain the hermeticity with the inlet tube, the first outlet tube, and the second outlet tube.
The inlet tube having a first support vane surrounding the outer wall surface of the first inner inlet section on the outside and a second support vane surrounding the inlet section,
The retainer is mounted between the first support vane and the inner wall surface of the second inner inlet portion and between the outer wall surface of the inlet portion and the second support vane to maintain airtightness while the second chamber rotates independently do.
A bearing is further provided between the first support vane and the inner wall surface of the second inner inlet portion and between the outer wall surface of the inlet portion and the second support vane to smooth the rotation of the second chamber together with the retainer do.
The injection pipe is inserted to the lower end of the upper body part, and the first discharge pipe is inserted to a height of 0.1 mm to 2 mm from the bottom face of the lower body part.
At least one second wing portion for smoothly stirring the second chamber when the second chamber rotates is formed in the inner wall surface from the cell separation portion to the lower end of the upper body portion in the direction of the injection tube.
The lower plate portion is integrally formed at the lower ends of the first inner inlet portion and the second inner inlet portion and the lower ends of the first inner inlet portion and the second inner inlet portion and has a slope equal to the slope of the upper plate portion, And at least one passage is provided between the upper plate and the lower plate, and a circular plate portion between the passage and the passage is bonded to the upper plate.
By adjusting the rotational speed of the second chamber and the length of the circular plate, it is possible to collect blood components according to the blood component layer formed inside by the centrifugal force of the second chamber, and the physiological buffer solution other than the regenerative cells Adjust the amount left in the chamber.
The lower plate portion is integrally formed at the lower ends of the first inner inlet portion and the second inner inlet portion and the lower ends of the first inner inlet portion and the second inner inlet portion and has a slope equal to the slope of the upper plate portion, A circular plate that extends and forms the passage with the top plate portion and a hollow flat plate shape surrounding the outside of the second inner inlet portion of the bottom plate portion and selectively connecting at least one passage among the passages to the second outlet pipe Wherein at least one passage is provided between the upper plate and the lower plate, a circular plate portion between the passage and the passage is bonded to the upper plate, and when the circular plate is divided in the radial direction, The weights of the respective half portions are equal to each other, the lengths of the passages formed in one half portion are different from each other, Wherein the upper and lower surfaces of the first and second discharge ports are formed to have the same length, and the upper surface of the selective discharge portion has a through hole passing through the second inner inlet portion at the center thereof, A side discharge hole connected to the selected passage is formed on the side surface and a lower end portion of the side surface is coupled to a coupling groove formed on the upper surface of the circular plate, the selective discharge portion is tightly coupled to the coupling groove, Thereby selecting the passage.
And a filtration screen capable of holding undigested tissue or a collagen mass among the liquid cells injected through the injection tube is further installed inside the lower body part under the injection tube.
The lower plate portion is integrally formed at the lower ends of the first inner inlet portion and the second inner inlet portion and the lower ends of the first inner inlet portion and the second inner inlet portion and has a slope equal to the slope of the upper plate portion, A circular plate part integrally formed at an end of the circular plate and having a plurality of cylindrical vanes formed at an inner side thereof and a circular plate part surrounding the outer side of the second inner inlet part of the lower plate part, And a hollow flat circular plate-shaped selective discharge portion for selecting at least one cylindrical wing and connecting the passage inside the selected cylindrical wing to the second discharge pipe, wherein the upper surface of the cylindrical wings is bonded to the upper plate portion, So that the blood component layer formed therein can be separated by the centrifugal force of the second chamber to collect the component blood A top discharge hole communicating with the second discharge pipe at both sides of the through hole is formed at an upper portion of the selective discharge portion and a side discharge hole communicating with the selected discharge passage is formed at a side of the selective discharge portion, And a lower end of the side surface is coupled to a coupling groove formed on an upper surface of the circular plate. The selection and discharge unit is tightly coupled to the coupling groove and then rotated to select the cylindrical vane.
The lower plate portion is integrally formed at the lower ends of the first inner inlet portion and the second inner inlet portion and the lower ends of the first inner inlet portion and the second inner inlet portion and has a slope equal to the slope of the upper plate portion, And a circular plate part having a circular plate spread, an end of the circular plate, and a plurality of cylindrical vanes, one end of which is connected to the inner wall surface of the second chamber and the passage is formed inside and the other end is weight- The wings are made of an elastic material, and the weights mounted on the respective vanes have different weights or weights to balance the vanes, and the weight of the wings is determined according to the centrifugal force due to the rotation of the second chamber The cylindrical vanes are opened in the direction of the inner wall surface of the second chamber and component blood can be collected according to the blood component layer.
The circular plate portion has two symmetrical cylindrical blades, and the weight mounted on the cylindrical blades has the same weight.
The transfer unit includes a first multiway valve connected to the plurality of bags, a first multiway valve connected to the first unit and the second unit, and a second multiway valve connected to the first multiway valve, And a pump connecting the second multiway valve.
The transfer unit includes a plurality of solenoid valves connected to the plurality of bags instead of the first and second multiway valves, and a transfer pipe controlled by the solenoid valves is connected to the pump.
The transferring unit is inserted with a transfer filter which can remove foreign matter such as undegraded enzyme masses or collagen masses contained in the liquid cells transferred from the first unit to the second unit. The transport filter is a doubly-fed filter.
The first unit and the second unit are each equipped with jigs to be rotated at a constant temperature, and the temperature and rotational speed of the first and second units can be adjusted.
As described above, the regenerative cell extracting system according to the embodiment of the present invention enables complete automation controlled by a program from the collection of adipose tissue to the extraction of regenerated cells, and the adipose tissue is moved and separated in a closed state, It is advantageous to selectively obtain fat tissue, mature fat cells, oil (fat), and fat-derived stem cells at each step in the separation of adipose tissue, and even when large volume such as breast enlargement is desired, It is very convenient to obtain many pure fat and fat-derived stem cells. In addition, by selectively changing the structure of the lower plate in the second chamber, it is possible to selectively separate necessary components from the blood. In this case, the desired tissue can be continuously separated even if the volume of the second chamber is large .
In addition, by automating both the rotational speed and other operations of the first unit and the second unit by a program, it is possible to automatically perform a predetermined time and capacity from the extraction of the tissue to the collection and storage of stem cells. In addition, by attaching a filter to the transfer part, various cells including stem cells can be separated from various tissues.
In order to fully understand the present invention, operational advantages of the present invention, and objects achieved by the practice of the present invention, reference should be made to the accompanying drawings and the accompanying drawings which illustrate preferred embodiments of the present invention.
BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in detail with reference to the preferred embodiments of the present invention with reference to the accompanying drawings. Like reference symbols in the drawings denote like elements.
1 is a conceptual diagram illustrating a regenerative cell extraction system according to an embodiment of the present invention.
Referring to FIG. 1, a regenerative
The
The
That is, the
That is, the
The
Although many regenerative cell extraction devices have been developed for collecting cells from adipose tissue, as described in the prior art, these devices do not adequately accommodate a suction device for collection of adipose tissue, It is not fully automated until the processing of the tissue, and does not have a complete sealing system. Also, the system in the process of concentrating the desired cells is different from the present invention.
The regenerative
That is, the regenerative
Therefore, the risk of contamination is low and the work process is simple, compared with a case where a tissue collected from a human body is once put in a separate bag and then transferred to a regenerative cell extracting apparatus.
The
When the
The
The first multi-way valve may use the same number of passages as the number of bags (B1, B2-Bn), and the number of passages of the second multi-way valve may be equal to or less than the number of passages of the first multi- have. The pump is disposed between the first multi-way valve and the second multi-way valve and allows material to move between the first multi-way valve and the second multi-way valve. A peristertic pump may be used as the pump.
The
The structure and operation of the
2 (a) is a cross-sectional view for explaining the structure of the first unit.
Referring to FIG. 2 (a), the
The
The
The
The size of the
That is, when the capacity is less than 1,000 cc, the height of the
The
Tissue is introduced into the
A transfer bag is connected to the top of the
The
The retainer is a component that functions to assist rotation such as a bearing, but also to seal air so that it does not pass through. It is natural that elements other than the retainer can be used.
A bearing (not shown) for smoothly rotating the
The sound-
At least one
In addition, the
The
In addition, the
The operation of the
First, it absorbs fat tissue from the body (Fat tissue aspiration)
The cap on the upper portion of the
The lid of the upper portion of the
After collecting adipose tissue, remove the connection tube between the needle and the vacuum inhaler. At this time, the cap on the connection side of the vacuum inhaler is left unopened for a while. That is, the connection to the vacuum inhaler is removed first, and the inside of the
The
A kit for an adipose-derived stem cell of the
Second, the blood contaminants are removed (pure fatty tissue separation).
The
The
The
(Weight) of the substance including blood and the specific gravity (weight) of the fat tissue are different, so that the operation of the pump can be controlled by sensing the difference in specific gravity. Since the operation of such a sensor can be understood by those skilled in the art, a detailed description will be omitted.
A cleaning water (saline solution) bag is opened and an amount of washing water similar to that of the fatty tissue remaining in the
In this manner, the operation of washing the adipose tissue with the saline solution, removing the washed portion of the water again, and washing with the saline solution is repeated 3-5 times. Finally, the saline solution is removed. Only the fat tissue necessary for separating the fat-derived stem cells is left in the
Third, the cells are separated using enzymes.
A similar amount of enzyme (0.1% collagenase, as used in the washed fat cells) remains in the
After the enzyme is added, the rotation and stop of the
When the rotation and stopping are repeated for a predetermined time (for example, about 30 minutes), the mature fat cells and fat-derived cells are decomposed by the enzyme in the
As described above, the
Fig. 2 (b) is a view showing another structure of the first unit of Fig. 2 (a).
2 (b), the sound-
3 is a cross-sectional view illustrating the structure of the second unit.
4 is a plan view for explaining the structure of the lower plate portion of Fig.
3 and 4, the
The
The
In addition, when the liquid containing the adipose-derived stem cells continuously flows from the
The
The
The
The
Preferably, the
The upper portion of the
The
The
In the
The
That is, between the inner wall surface of the
The retainer is an element that functions to assist rotation such as a bearing while sealing the air so that it does not pass through. It is a matter of course that an element performing such a function may be used in addition to the retainer, A bearing that smoothly rotates the two
The
The
At least one
4, a
By adjusting the rotation speed of the
A
The
Hereinafter, the operation of the
First, an enzyme contained in the sap containing the regenerative cells transferred from the first unit 100 (a physiological buffer containing various culture media, etc.) is washed and the volume of the solution is reduced, so that the volume reduction ) Process is performed.
The saline solution containing the collagenase and the cells from the
Similarly to the
Such programs and automation can be understood by those skilled in the art and will not be described in detail.
Simultaneously with the start of rotation of the
After about 5 minutes, the
As described above, the
Second, the rotation of the
Finally, the plug at the top of the
In the case where the amount of adipose tissue collected from the body is not sufficient, the whole process is performed only with the
Fig. 5 is a plan view for explaining another structure of the lower plate portion of Fig. 3;
Fig. 6 (a) is a plan view of the selective discharge portion coupled to the lower plate portion of Fig. 5;
6 (b) is a side sectional view of the selective discharge portion.
6 (c) is a sectional view of the second unit for explaining a structure in which the selective discharge portion is coupled to the lower plate portion.
5 to 6, a lower plate portion 264-1 according to another embodiment of the present invention includes a first
At least one passage 265-1 is provided between the
When separating the circular plate 260-1 in the radial direction, the separated half portions have the same weight, the lengths of the passages formed in one half portion are different from each other, Passages facing each other have the same length.
That is, as shown in FIG. 5, the circular plate 260-1 has a structure in which the passages 265-1 having different lengths from short to long are symmetrical to each other.
By making the lengths of the passages 265-1 to be different from each other, it is possible to obtain a desired substance at a necessary position when different substances are to be obtained in each layer generated as a result of centrifugation of blood or the like by rotation of the
The reason for having a symmetrical structure is that vibrations may occur in the rotating
A through
A
6 (c), the
The
Fig. 7 is a plan view for explaining another structure of the lower plate portion of Fig. 3;
8 is a cross-sectional view illustrating a state in which the lower plate portion of Fig. 7 is mounted.
7 is a plan view of the lower plate portion 264-2 and a top view and a side view of the
7 and 8, the other structure of the lower plate portion 264-2 according to the embodiment of the present invention is different from the structure of the
More specifically, the lower plate portion 264-2 includes a first
The
The
8, the upper surfaces of the
That is, when the
The upper surface of the
A
7, the
8, the
By making the length of the
As shown in FIG. 7, the inner wall surface 263-2 of the
9 is a cross-sectional view illustrating a state in which the lower plate of another structure is mounted in the second chamber.
The lower plate portion has a first
9,
If there are two cylindrical wings, the weight attached to the cylindrical wing should have the same weight.
When the
Since the centrifugal force acts on the outside of the
The
There are various ways in which the
The
As described above, various cells including stem cells can be isolated from various tissues other than adipose derived stem cells by the filter mounted on the
As described above, an optimal embodiment has been disclosed in the drawings and specification. Although specific terms have been employed herein, they are used for purposes of illustration only and are not intended to limit the scope of the invention as defined in the claims or the claims. Therefore, those skilled in the art will appreciate that various modifications and equivalent embodiments are possible without departing from the scope of the present invention. Accordingly, the true scope of the present invention should be determined by the technical idea of the appended claims.
BRIEF DESCRIPTION OF THE DRAWINGS A brief description of each drawing is provided to more fully understand the drawings recited in the description of the invention.
1 is a conceptual diagram illustrating a regenerative cell extraction system according to an embodiment of the present invention.
2 (a) is a cross-sectional view for explaining the structure of the first unit.
Fig. 2 (b) is a view showing another structure of the first unit of Fig. 2 (a).
3 is a cross-sectional view illustrating the structure of the second unit.
4 is a plan view for explaining the structure of the lower plate portion of Fig.
Fig. 5 is a plan view for explaining another structure of the lower plate portion of Fig. 3;
Fig. 6 (a) is a plan view of the selective discharge portion coupled to the lower plate portion of Fig. 5;
6 (b) is a side sectional view of the selective discharge portion.
6 (c) is a sectional view of the second unit for explaining a structure in which the selective discharge portion is coupled to the lower plate portion.
Fig. 7 is a plan view for explaining another structure of the lower plate portion of Fig. 3;
8 is a cross-sectional view illustrating a state in which the lower plate portion of Fig. 7 is mounted.
9 is a cross-sectional view illustrating a state in which the lower plate of another structure is mounted in the second chamber.
Claims (24)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090102082A KR101679671B1 (en) | 2009-10-27 | 2009-10-27 | System for extracting regenerative cells |
PCT/KR2010/007339 WO2011052946A2 (en) | 2009-10-27 | 2010-10-25 | Regenerative cell extraction system |
JP2012536661A JP5826183B2 (en) | 2009-10-27 | 2010-10-25 | Regenerative cell extraction system |
CN2010800538086A CN102869761A (en) | 2009-10-27 | 2010-10-25 | Regenerative cell extraction system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090102082A KR101679671B1 (en) | 2009-10-27 | 2009-10-27 | System for extracting regenerative cells |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160045633A Division KR20160045050A (en) | 2016-04-14 | 2016-04-14 | System for extracting regenerative cells |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110045479A KR20110045479A (en) | 2011-05-04 |
KR101679671B1 true KR101679671B1 (en) | 2016-11-28 |
Family
ID=43922788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090102082A KR101679671B1 (en) | 2009-10-27 | 2009-10-27 | System for extracting regenerative cells |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP5826183B2 (en) |
KR (1) | KR101679671B1 (en) |
CN (1) | CN102869761A (en) |
WO (1) | WO2011052946A2 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012006587A2 (en) | 2010-07-09 | 2012-01-12 | The Gid Group, Inc. | Apparatus and methods relating to collecting and processing human biological material containing adipose |
US9206387B2 (en) | 2010-07-09 | 2015-12-08 | The Gid Group, Inc. | Method and apparatus for processing adipose tissue |
WO2013106655A1 (en) | 2012-01-11 | 2013-07-18 | The Gid Group, Inc. | Method for processing adipose tissue and processing apparatus |
US9296984B2 (en) | 2010-07-09 | 2016-03-29 | The Gid Group, Inc. | Tissue processing apparatus and method for processing adipose tissue |
KR101316575B1 (en) * | 2011-12-14 | 2013-10-15 | 도병록 | Peristaltic pump and System for extracting regenerative cells using the same |
KR101357160B1 (en) * | 2011-12-14 | 2014-02-17 | 주식회사 휴림바이오셀 | System and method for extracting regenerative cells |
EP3075841B1 (en) * | 2012-09-06 | 2021-03-10 | GID BIO, Inc. | Tissue processing apparatus and method for processing adipose tissue |
KR101466923B1 (en) * | 2013-01-17 | 2014-12-04 | 주식회사 휴림바이오셀 | Device and System for extracting regenerative cells and Method for extracting regenerative cells using the same |
KR20150124982A (en) * | 2013-03-04 | 2015-11-06 | 스위스 스템 셀 파운데이션 | A system for extraction of cells from a sample of tissue |
KR101313048B1 (en) * | 2013-04-09 | 2013-09-30 | 김준우 | Dividing device for cell fractions or blood elements |
KR101343577B1 (en) * | 2013-05-03 | 2013-12-20 | 김준우 | Dividing device for cell fractions or blood elements |
EP3038629B1 (en) * | 2013-09-05 | 2020-11-18 | GID BIO, Inc. | Method for processing adipose tissue |
CN103604679B (en) * | 2013-11-25 | 2015-12-30 | 武汉友芝友医疗科技有限公司 | A kind of circulating tumor cell is caught instrument and catches colouring method |
WO2015167768A1 (en) | 2014-05-02 | 2015-11-05 | Lifecell Corporation | Injection sensor with feedback mechanism |
CN106661527B (en) * | 2014-07-08 | 2019-09-20 | Cg生物技术有限公司 | Cell separation vessel, cell separation system and cell isolation method |
KR101667848B1 (en) * | 2014-07-08 | 2016-10-19 | (주)시지바이오 | Container for separating stem cells from fattissue and method for separating stem cells from fattissue using the same |
KR101707474B1 (en) * | 2015-03-13 | 2017-02-17 | 주식회사 디더블유메디팜 | Integrated valve unit and nucleated cell extraction device using the same |
CN108350424A (en) | 2015-10-21 | 2018-07-31 | 生命细胞公司 | System and method for pipe fitting management |
CA3002538A1 (en) | 2015-10-21 | 2017-04-27 | Lifecell Corporation | Systems and methods for medical device control |
AU2016378566A1 (en) | 2015-12-22 | 2018-06-28 | Lifecell Corporation | Syringe filling device for fat transfer |
KR101736374B1 (en) * | 2016-06-07 | 2017-05-17 | (주)시지바이오 | A bowl for a centrifuge and method for separation of stromal vascular fraction using the same |
AU2017319140B2 (en) | 2016-08-30 | 2022-11-17 | Lifecell Corporation | Systems and methods for medical device control |
USD851777S1 (en) | 2017-01-30 | 2019-06-18 | Lifecell Corporation | Canister-type device for tissue processing |
CN107118944A (en) * | 2017-06-19 | 2017-09-01 | 方育峰 | A kind of device for improving fat cell survival rate in autologous fat DaphniaCarinat a |
US11732233B2 (en) | 2017-07-18 | 2023-08-22 | Gid Bio, Inc. | Adipose tissue digestion system and tissue processing method |
CN107475098B (en) * | 2017-08-15 | 2023-08-15 | 中国人民解放军第二军医大学第二附属医院 | Rapid homogenization split charging device and method for subpatellar fat pad under aseptic condition |
KR20210108048A (en) * | 2020-02-25 | 2021-09-02 | (주)시지바이오 | Centrifuging vessel |
CN114315993B (en) * | 2021-12-27 | 2022-09-02 | 江苏艾洛特医药研究院有限公司 | Bacterial flagellum purification device |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001017540A (en) | 1999-06-03 | 2001-01-23 | Haemonetics Corp | Blood processing centrifugal separation bowl and method for collecting plasma fractions |
JP2009189282A (en) | 2008-02-13 | 2009-08-27 | Olympus Corp | Centrifugal separation container |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3202145A1 (en) * | 1982-01-23 | 1983-08-11 | A. u. K. Müller GmbH & Co KG, 4000 Düsseldorf | MULTI-WAY VALVE, ESPECIALLY FOR USE IN DIALYSIS DEVICES |
JPH05310781A (en) * | 1992-05-13 | 1993-11-22 | Mitsui Toatsu Chem Inc | Improved production of crystal of l-alpha-aspartyl-l-phenylalanine methyl ester |
JP3339130B2 (en) * | 1993-09-28 | 2002-10-28 | 東北電力株式会社 | Chemical cleaning method |
JPH07231776A (en) * | 1994-02-24 | 1995-09-05 | Kirin Eng Kk | Apparatus for producing fermented sugar |
BR9508456A (en) * | 1994-07-29 | 1997-12-23 | Gambro Ab | Process and device for measuring the concentration of urea or a similar substance in a composite solution |
JP3313572B2 (en) * | 1996-04-03 | 2002-08-12 | ヘモネティクス・コーポレーション | Blood processing centrifuge bowl |
US6629919B2 (en) * | 1999-06-03 | 2003-10-07 | Haemonetics Corporation | Core for blood processing apparatus |
MXPA06000062A (en) * | 2003-06-25 | 2006-04-07 | Macropore Biosurgery Inc | Systems and methods for separating and concentrating regenerative cells from tissue. |
JP2006020756A (en) * | 2004-07-07 | 2006-01-26 | Terumo Corp | Centrifugal separator and blood component sampling circuit |
EP1885382B1 (en) * | 2005-05-25 | 2011-03-02 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
JP5036026B2 (en) * | 2006-03-09 | 2012-09-26 | 旭化成株式会社 | Blood component separation device and method of use thereof |
JP2007282552A (en) * | 2006-04-14 | 2007-11-01 | Biomaster Inc | Method for cell separation and system for cell separation |
US20080102493A1 (en) * | 2006-06-29 | 2008-05-01 | Millipore Corporation | Isolation of RNA and DNA from a biological sample |
JP2008131881A (en) * | 2006-11-28 | 2008-06-12 | Kirin Brewery Co Ltd | Apparatus and method for debittering yeast |
-
2009
- 2009-10-27 KR KR1020090102082A patent/KR101679671B1/en active IP Right Grant
-
2010
- 2010-10-25 JP JP2012536661A patent/JP5826183B2/en not_active Expired - Fee Related
- 2010-10-25 CN CN2010800538086A patent/CN102869761A/en active Pending
- 2010-10-25 WO PCT/KR2010/007339 patent/WO2011052946A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001017540A (en) | 1999-06-03 | 2001-01-23 | Haemonetics Corp | Blood processing centrifugal separation bowl and method for collecting plasma fractions |
JP2009189282A (en) | 2008-02-13 | 2009-08-27 | Olympus Corp | Centrifugal separation container |
Also Published As
Publication number | Publication date |
---|---|
CN102869761A (en) | 2013-01-09 |
KR20110045479A (en) | 2011-05-04 |
JP5826183B2 (en) | 2015-12-02 |
JP2013507983A (en) | 2013-03-07 |
WO2011052946A3 (en) | 2011-11-03 |
WO2011052946A2 (en) | 2011-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101679671B1 (en) | System for extracting regenerative cells | |
US20230159881A1 (en) | Adipose tissue centrifuge and method of use | |
KR101316573B1 (en) | System and unit for extracting regenerative cells | |
JP4961354B2 (en) | Platelet rich plasma concentration apparatus and method | |
ES2625893T3 (en) | Systems, procedures and compositions to optimize grafts enriched with tissue and cells | |
KR101127305B1 (en) | Systems and methods for separating and concentrating regenerative cells from tissue | |
US7708152B2 (en) | Method and apparatus for preparing platelet rich plasma and concentrates thereof | |
JP5925962B2 (en) | Centrifugal dynamic filtration device and cell separation system using the same | |
US20210147788A1 (en) | Isolation device for adipose-derived stromal vascular fraction | |
ES2837096T3 (en) | Device for isolating cell fractions from human and animal tissues and procedure for their use | |
ES2884348T3 (en) | Cell separation, dissociation and / or disaggregation using mechanical impacts | |
KR20160045050A (en) | System for extracting regenerative cells | |
KR101316574B1 (en) | Multiway valve and System for extracting regenerative cells using the same | |
CN110935072A (en) | Device for integrally treating adipose tissues and treatment method thereof | |
KR101013927B1 (en) | Method for Isolating stem cell | |
KR102513350B1 (en) | Centrifugal dehydrator |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |